Triamcinolone acetonide preparations: Impact of crystal size on in vitro behavior

Retina

Volumn 29, Issue 5, 2009, Pages 689-698

  Moshfeghi, Andrew A ^a   Nugent, Alex K ^b   Nomoto, Hiroyuki ^b   Sanislo, Steven R ^b   Kitchens, John W ^c   Moshfeghi, Darius M ^b,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Retina Associates of Kentucky   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; CRYSTALLIN; TRIAMCINOLONE ACETONIDE; TRIESENCE; TRIVARIS; UNCLASSIFIED DRUG; EYE DROPS; GLUCOCORTICOID; PRESERVATIVE;

ABSORPTION SPECTROPHOTOMETRY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG SYNTHESIS; IMAGE PROCESSING; IN VITRO STUDY; SUSPENSION; CHEMISTRY; CRYSTALLIZATION; MICROSCOPY; SPECTROPHOTOMETRY;

CRYSTALLIZATION; GLUCOCORTICOIDS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; SPECTROPHOTOMETRY; TRIAMCINOLONE ACETONIDE;

EID: 66349123334     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31819e390a     Document Type: Article

References (29)

1. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseu-dophakic cystoid macular edema. J Cataract Refract Surg 2003;29:27-33.
2. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139: 972-982.
3. Cekiç O, Chang S, Tseng JJ, et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005;25:851-855.
4. Gregori NZ, Rosenfeld PJ, Puliafito CA, et al. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina 2006;26:889-895.
5. Goff MJ, Jumper JM, Yang SS, et al. Intravitreal triamcino-lone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina 2006;26:896-901.
6. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427.
7. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
8. Kim JE, Pollack JS, Miller DG, Mittra RA, Spaide RF; Isis Study Group. ISIS-DME: a prospective, randomized, doseescalation intravitreal steroid injection study for refractory diabetic macular edema. Retina 2008;28:735-740.
9. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110:151.
10. Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 2005;112:1916.
11. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 2001;29: 2-6.
12. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24-27.
13. Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 2004; 138:489-492.
14. Moshfeghi DM, Kaiser PK, Bakri SJ, et al. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging 2005;36: 24-29.
15. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endoph- thalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
16. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000; 20:554-555.
17. Sonoda KH, Sakamoto T, Enaida H, et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 2004; 111:226-230.
18. Burk SE, Da Mata AP, Snyder ME, Schneider S, Osher RH, Cionni RJ. Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg 2003;29:645-651.
19. Kimura H, Kuroda S, Nagata M. Triamcinolone acetonide-assisted peeling of the internal limiting membrane. Am J Ophthalmol 2004;137:172-173.
20. Yeung CK, Chan KP, Chan CK, Pang CP, Lam DS. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn J Ophthalmol 2004;48:236-242.
21. Shaikh S, Ho S, Engelmann LA, Klemann SW. Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 2006;90:233-236.
22. Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kupper- mann BD. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 2006;47:722-728.
23. Chang YS, Wu CL, Tseng SH, Kuo PY, Tseng SY. Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2007;48:2792-2798.
24. Chang YS, Wu CL, Tseng SH, Kuo PY, Tseng SY. In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide. Exp Eye Res 2008;86:942-950.
25. TRIESENCE®. Prescribing Information. Available at: http://a1020. g.akamai.net/7/1020/2226/33a421e366e1a6/www.alcon.com/docs/ ars-Triesence-pi. pdf. Accessed July 28, 2008.
26. TRIVARIS™. Prescribing Information. Available at: http://www. allergan.com/assets/pdf/trivaris-pi.pdf. Accessed July 28, 2008.
27. Bakri SJ, Shah A, Falk NS, Beer PM. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema. Eye 2005;19:686-688.
28. Rasband WS. Image J. Bethesda, MD: US National Institutes of Health; 1997-2007. Available at: http://rsb.info.nih.gov/ij/. Accessed November 1, 2008.
29. Francis BA, Chang EL, Haik BG. Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice. Ophthalmology 1996;103:1884-1888.